Absci to participate at the inaugural gilmartin group emerging growth company showcase

Vancouver, wash. and new york, aug. 24, 2022 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today announced the company will present at the upcoming inaugural gilmartin group emerging growth company showcase, taking place virtually.
ABSI Ratings Summary
ABSI Quant Ranking